Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities.

Address: Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Molecular Pathology of Lymphoid Neoplasms, Fundació de Recerca Clinic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany.; Genomics and Transcriptomics Laboratory, University of Düsseldorf, Düsseldorf, Germany.; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany.; European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research, Ludwig-Maximilians-University Hospital, Munich, Germany.; Department of Pathology, University of Heidelberg, Heidelberg, Germany.; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany.; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research, Ludwig-Maximilians-University Hospital, Munich, Germany.; German Cancer Consortium, Munich, Germany.; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Molecular Medicine Partnership Unit, Heidelberg, Germany. [email protected].; European Molecular Biology Laboratory, Heidelberg, Germany. [email protected].; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany. [email protected].; Molecular Medicine Partnership Unit, Heidelberg, Germany. [email protected].; European Molecular Biology Laboratory, Heidelberg, Germany. [email protected].; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany. [email protected].; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany. [email protected].